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Abstract
Neurodegeneration in protein-misfolding disease is generally assigned to toxic function of small, soluble protein
aggregates. Largely, these assignments are based on observations of cultured neural cells where the suspect protein
material is titrated directly into the growth medium. In the present study, we use this approach to shed light on the
cytotoxic action of the metalloenzyme Cu/Zn superoxide dismutase 1 (SOD1), associated with misfolding and aggregation
in amyotrophic lateral sclerosis (ALS). The results show, somewhat unexpectedly, that the toxic species of SOD1 in this type
of experimental setting is not an aggregate, as typically observed for proteins implicated in other neuro-degenerative
diseases, but the folded and fully soluble apo protein. Moreover, we demonstrate that the toxic action of apoSOD1 relies on
the protein’s ability to chelate Zn
2+ ions from the growth medium. The decreased cell viability that accompanies this
extraction is presumably based on disturbed Zn
2+ homeostasis. Consistently, mutations that cause global unfolding of the
apoSOD1 molecule or otherwise reduce its Zn
2+ affinity abolish completely the cytotoxic response. So does the addition of
surplus Zn
2+. Taken together, these observations point at a case where the toxic response of cultured cells might not be
related to human pathology but stems from the intrinsic limitations of a simplified cell model. There are several ways
proteins can kill cultured neural cells but all of these need not to be relevant for neurodegenerative disease.
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Introduction
In neurodegenerative diseases, the pathogenesis has in multiple
cases been linked to misfolding and aggregation of proteins and
peptides [1]. The mechanism by which these misfolded or
aggregated proteins exert toxicity to neural cells, however, is not
clear. One reason is that studies of misfolding and aggregation
phenomena are generally complicated by the elusive nature of
unstructured and partly unfolded proteins. Also, the actual toxicity
response is often difficult to pin down at physiological level due to
the complexity of even the most simplistic cell models. To shed
further light on these issues we examine here the cytotoxic
response of cultured neuroblastoma cells to the metal-coordinating
enzyme Cu/Zn superoxide dismutase (SOD1) implicated in the
neurodegenerative disorder amyotrophic lateral sclerosis (ALS). A
particular advantage of this model is that SOD1 has a well-
characterized three-dimensional structure [2] that is amenable to a
wide spectrum of biophysical analyses as well as extensive
modifications by protein engineering [3,4,5]. In addition, by using
a fairly simple cell model where the protein is added directly to the
cell media, the concentration and biophysical properties of SOD1
can be more accurately controlled. Disease relevance of this
reductionist model is provided by the implicated extracellular role
of SOD1 in propagating damage in the central nervous tissue.
Even though SOD1 exist as an intracellular protein in vivo, and
hence ALS is most likely triggered intracellularly, the neural
damage seems to be able to propagate to neighbouring cells [6]. As
an explanation to how this occurs, SOD1 has been demonstrated
to interact with chromogranins, a component of secretory vesicles,
possibly promoting the secretion of SOD1 [7]. The contribution of
extracellular SOD1 is further highlighted by the ability of SOD1
to trigger neural death when added extracellularly to cultured cells
[7] as well as in stem-cell derived motor neurons cultured together
with glia cells expressing mutant SOD1 [8,9].
The SOD1 gene comprises .140 different missense mutations
associated with familial ALS [10], which provide a uniquely large
reference set for mapping out the molecular determinants of the
disease. Accordingly, the most likely precursor for ALS has been
identified as the fully, or partly, metal-depleted apoSOD1 protein
[3,11,12], and the mutational perturbations that seem to inflict
disease are decreased protein stability [3,11,13] and reduced
repulsive charge [14]. Even so, the data relating to how apoSOD1
induces neural damage have been quite disparate, illustrating
partly the complexity of inferring disease mechanism from
simplistic cellular model systems. One line of evidence favours
toxic aggregation [15,16,17] and overload of the cellular
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radical chemistry catalysed by the Zn
2+-depleted enzyme [20]. By
designing the experiment so that neither of these putative toxic
pathways can be engaged, we demonstrate here that SOD1 is still
able to exert toxicity to cultured cells. The basis for this toxicity, as
it turns out, involves an intact un-metallated Zn
2+-site, as addition
of Zn
2+ to the culture media or disruption of the Zn
2+-site using
protein engineering completely inhibits toxicity. Thus, the toxic
response of apoSOD1 closely resembles the toxicity of low
molecular weight Zn
2+ chelators, i.e. apoSOD1 presumably
disturbs cellular Zn
2+ homeostasis, thereby causing a cytotoxic
response. This additional toxicity effect of apoSOD1 underlines
not only the multiplicity of ways cultured cells can respond to a
single disease-associated protein, but is also interesting by exposing
a case where the physiological relevance of the cellular response is
questionable. The toxic action of apoSOD1 in cell cultures is
unlikely part of the human ALS mechanism.
Results
Monomeric and dimeric apoSOD1 reduce cell viability of
cultured neuroblastoma cells
The active SOD1 enzyme exists within the cell as a dimeric
metallated holo protein, with each subunit containing one redox-
active Cu
1+/2+ ion and one Zn
2+ ion. However, a small fraction of
the SOD1 molecules are expected to reside in their metal-free apo
form, as metal loading is dependent on the availability of metals as
well as the copper chaperone for SOD1 (CCS) [21]. To be able to
study the monomeric protein, two dimer splitting mutations were
introduced; F50E and G51E [22]. In addition, in both monomeric
and dimeric protein, C6 and C111 were substituted for alanine to
avoid aggregation by disulfide cross-linking [23,24]. Notably, this
mutant leaves the intramolecular disulphide bridge between C57
and C146 intact. The monomeric [C6/111A;F50E;G51E] protein
is throughout the paper referred to as monomer, and the [C6/
111A] protein as dimer. To assess the impact on cell viability of
these proteins, monomeric and dimeric SOD1 in apo or holo form
were added to the cell media of cultured human neuroblastoma
cells (SH-SY5Y) [25]. Cell viability was evaluated after 72 hours
using the MTT or resazurin assays, measuring cellular metabolic
activity. The cells were also inspected microscopically before
addition of MTT. These inspections were in all cases consistent
with the result of the MTT assay.
The results show that both monomeric and dimeric apoSOD1
inhibited MTT reduction in the low mM range, demonstrating
reduced cell viability, whereas the viability of cells exposed to
holoSOD1 remained high (Figure 1A). The same result was
observed when using the resazurin assay and in one additional
human neuroblastoma cell line (IMR-32) [26], as well as in PC-12
cells from rat pheochromocytoma (Figure S1). To examine more
closely the morphology of cells exposed to apoSOD1, SH-SY5Y
cells were stained with an anti-tubulin antibody to visualize
cytoskeletal alterations. After 72 h of incubation with monomeric
apoSOD1, remaining cells displayed distorted and twisted neurites
(Figure 1C), whereas cells incubated with holoSOD1 displayed
normal morphology (Figure 1B). Images at lower magnification
clearly show a reduced number of cells left on the surface after
exposure to apoSOD1 (Figure S2).
The reduced cell viability caused by apoSOD1 does not
depend on protein aggregation
Even if apoSOD1 is relatively resistant to spontaneous
aggregation in vitro, it can readily be provoked to form fibrillar
structures upon destabilization or agitation by stirring [23,27,28].
As protein aggregation has been associated with reduced viability
in cell cultures, both for disease associated [29] and non-disease
associated proteins [30], the significance of aggregation for
cytotoxicity induced by apoSOD1 was evaluated. Monomeric
and dimeric apoSOD1 were analyzed by size-exclusion chroma-
tography, and fractions were collected and subsequently incu-
bated with cells. The fractions exerting high toxicity had an
elution volume corresponding to monomeric (Figure 2B) and
dimeric (Figure 2A) protein, suggesting that these are the main
cytotoxic species. A small shoulder of larger species was observed
for the monomeric protein, but these fractions were essentially
inert.
To determine the aggregation state of dimeric apoSOD1 in
the cell media at the end of the experiments, the collected
conditioned cell media were separated by size-exclusion chroma-
tography and the collected fractions were analyzed with western
blot. After 72 h of incubation with cells, dimeric apoSOD1 still
remained dimeric in a concentration range from 0.16 to 12.5 mM
(Figure 2C), demonstrating a toxic response independent of
protein aggregation.
Figure 1. ApoSOD1 reduces viability of cultured cells. Apo and
holoSOD1 in dimeric and monomeric form were added to the cell
media of cultured SH-SY5Y cells and incubated for 72 h. Proteins were
added in duplicate wells and cell viability was measured with the MTT
assay. Cell viability is presented as the mean percentage viability of the
buffer control 6 range. Cell morphology was visualized with
immunocytochemistry, using DAPI for DNA staining (blue) and an
anti-tubulin antibody for staining of the cytoskeleton (red). (A) Both
monomeric (#) and dimeric (n) apoSOD1 induced a cytotoxic response
when added in mM concentrations (calculated as monomeric SOD1
concentration for both dimer and monomer). Neither monomeric (N)
nor dimeric (m) holoSOD1 induce toxicity in the same concentration
interval. (B) Monomeric holoSOD1 (5 mM) did not induce any
morphological cell alterations after 72 h of incubation (4006 magni-
fication). (C) Remaining cells after exposure to 5 mM monomeric
apoSOD1 for 72 h displayed an altered morphology characterized by
twisted and distorted neurites (4006magnification).
doi:10.1371/journal.pone.0036104.g001
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protein stability
Earlier studies have shown that apoSOD1 folds by a
cooperative two-state process [3,4],
U'F, ðScheme1:Þ
where U and F are the unfolded and folded species, respectively.
Accordingly, the relative occupancy of folded material at any given
condition is given by the equilibrium constant for folding
KU=F~½U =½F ð 1Þ
or, commonly, by the protein stability
DGU=F~{RT lnKU=F: ð2Þ
Thus, if the protein stability decreases the occupancy of unfolded
protein increases. From analysis of ALS associated SOD1
mutations it is apparent that decreased protein stability is one of
the key disease determinants, implicating unfolded, or partly
unfolded, protein as the starting material for toxic gain of function
[3,11]. In this study, however, we observe that the toxic responses
induced by apo monomers and dimers are of similar magnitudes,
despite the higher stability and lower occupancy of denatured
material of the apoSOD1 dimer (Figure 1A, Table 1) [4].
Somewhat unexpectedly, this implicates the fully folded apo
protein as the principal toxic species. To examine more closely the
effect of protein stability on cell viability in this model, we
examined the toxic effect of a set of mutants carrying mutations
altering protein stability (Table 1). Each mutation was introduced
into the monomeric SOD1 protein, and the stability of each
mutant was estimated by the thermal melting point using CD
spectroscopy (Eq. 3). Cell viability was measured after 72 h of
incubation with apo protein in a concentration range of 0 to
10 mM. Viability was expressed as the area under the curve where
buffer was set to 100% viability and monomeric apoSOD1 set to
0% (see Methods). When plotting viability as a function of protein
stability, a negative correlation was revealed, i.e. unstable mutants
were less toxic than mutants with wild-type like stability
(Figure 3A). Fit of a sigmoidal transition to the data yields a
midpoint of T50=38.3 uC (Eq. 5), close to the temperature under
which the experiments were conducted. In other words, mutants
with KU/F=[U]/[F]=1 at 37uC, i.e. constructs that are half
unfolded in the cell medium, exert half of the cytotoxic effect.
Although the uncertainty of this sigmoidal fit is high – the more
reductionist fit of a linear correlation is statistically as good - it
complies nicely with the observation that folded apoSOD1 is
responsible for the cytotoxic action in these experiments.
Generally, the mutations with melting temperature below the
experimental temperature, i.e. those that are predominantly
unfolded in the cell medium, are non-toxic whereas the more
stable, folded proteins are toxic. Notably, a toxicity mechanism
based on protein aggregation is expected to show the opposite
trend. Moreover, the correlation in Figure 3A is opposite to the
trend indicated in ALS patients, where decreased protein stability
is correlated with reduced survival time [3,11,13]; the toxic
precursor in ALS patients seems to be unfolded SOD1 material
whereas the toxic species in cultured cell seems to be the fully
folded apo protein. This questions the disease relevance of the
employed cell model. To further elucidate the molecular basis of
the toxic effect in cultured cells, another potential disease factor,
protein net charge [14], was investigated.
Alteration of protein net charge has no effect on cell
viability
Reduced net negative charge has previously been identified as a
disease-provoking property among ALS-associated SOD1 muta-
tions [14]. To study the effect of protein net charge on cell viability
in the model presented herein, the net charge of monomeric
SOD1 was increased by the mutations D11K, D96K and D109K,
individually or as double or triple mutants (c.f. Table 1). These
mutations alter the net charge of the protein from -8 to -6, -4 and -
2 at neutral pH (as calculated directly from the amino-acid
sequence at pH 7, assuming that the histidines are uncharged). In
addition, we produced a control mutant with six negatively
charged amino acids substituted for serines, [D11/92/96/109S;
Figure 2. The apoSOD1 molecules do not self-assemble in the
cell culture media. Dimeric and monomeric apoSOD (25 mM) were
applied to a Superdex 75 column and the eluted fractions were tested
for cytotoxicity in SH-SY5Y cells (black) and analysed for SOD1 by
western immunoblotting (red). Cell viability was measured with the
resazurin assay and presented as percentage viability of buffer control.
The peak areas from the western blot analysis have been normalised to
total amount of SOD1 in the chromatography. Cytotoxicity coincides
with the dimeric (A) and monomeric (B) peaks of the chromatograms.
(C) Analysis of the cell-culture medium directly after protein addition of
dimeric apoSOD1 and after 72 h incubation confirms that the apoSOD1
molecules remain dimeric throughout the toxicity assay. Large
molecules and aggregates would elute in the void volume of the
Superdex-75 column around fraction 26. The concentration of SOD1 in
the culture medium was varied between 0.16 mM (black), 0.625 mM
(purple), 1.25 mM (red), 2.5 mM (blue) and 12.5 mM (green).
doi:10.1371/journal.pone.0036104.g002
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96/109K] triple mutant but with no increase in the number of
positive amino acids. The thermodynamic stability of these charge
mutants was virtually identical to that of the monomeric wild-type
protein (Table 1). The results show that alteration of the net
negative charge by substituting D for K did not significantly alter
the toxic response. Also, the mutant [D11/92/96/109S; E24/
121S] retained a toxicity close to that of the wild-type protein
(Table 1). Again, the toxic response observed with cultured cells
does not follow the pattern of ALS-associated SOD1 mutations.
Demetallation of monomeric apoSOD1 increases
flexibility of loops IV and VII
Demetallation of SOD1 have previously been observed to
increase the dynamic motions of loops IV and VII [31,32],
pointing at the possibility that these parts of the structure are
involved in the cytotoxic action of the apo protein. The
augmented dynamics of loops IV and VII were confirmed for
Table 1. Melting temperature (Tm) and cell viability of
apoSOD1 protein variants.
SOD1 variant
Tm
a.
(6C)
Viability
b.
(%) Min/Max
c. n
d.
C6/111A;F50E;G51E 48.9 0 - -
C6/111A 54.2 16 - 1
I18V 43.7 (21.9) - 1
V29A 30.2 70 68/71 2
V31A 35.5 16 11/21 2
I35V 43.9 3.1 2.3/3.8 2
L38A 22.4 70 - 1
V47A 36.5 65 - 1
F64A 46.8 67 - 1
V81A 47.0 26 16/36 2
L84A 32.6 68 - 1
V87A 39.2 72.8 - 1
V97A 27.6 93 - 1
I104A 37.0 75 70/81 2
L106A 24.0 68 - 1
I112A 36.8 60 - 1
L117A 36.0 37 24/50 2
V119A 27.9 60 - 1
D124G 50.5 69 - 1
L144A 46.6 16 - 1
I149V 42.1 1.3 (20.6)/3.2 3
C6/57/1111/146A 33.4 83 64/94 3
D11K 49.1 4.1 (24.0)/18 3
D96K 49.6 19 12/23 3
D109K 52.2 10 2.2/22 3
D11/96K 48.9 6.9 4.8/9.2 3
D11/96/109K 51.0 17 12/22 3
D11/92/96/109S;E24/121S 50.0 31 - 1
H46/48/120S 49.2 17 - 1
H63/71/80S;D83S 51.8 80 73/90 4
H71/80S;D83S 50.9 84 68/93 3
H71/80S 49.6 73 59/87 2
H71S 49.7 78 63/94 2
H63/80S;D83S 50.2 100 98/102 2
H80S;D83S 50.3 99 98/99 2
H46/48/63/71/80/120S;D83S 50.4 63 62/65 2
a.The midpoint of the thermal unfolding transition monitored by CD, as derived
by fitting of a sigmoidal function (Eq. 3), using a DCp value of
1.4 kcal mol
21 K
21. This value was derived from the slope of DHU/F(Tm) vs. Tm
for the first 20 mutants in Table 1 (data not shown).
b.Mean cell viability expressed as percentage of buffer control with monomeric
apoSOD1 [C6/111A;F50E;G51E] set to 0%. Replicate values are displayed in
Figure 3A.
c.Min/Max represents the minimum and maximum viability response observed
for the individual mutations.
d.Number of cell viability experiments for the individual SOD1 mutations.
doi:10.1371/journal.pone.0036104.t001
Figure 3. ApoSOD1 with perturbed Zn
2+ site is non-toxic. A set
of apoSOD1 mutants with altered protein stability, charge and Zn
2+
binding capacity was added to SH-SY5Y cells in duplicate or triplicate in
a concentration range of 0.6 to 10 mM and incubated for 72 h. Cell
viability was measured with the MTT assay. (A) Relative cell viability was
calculated as described in methods, and plotted as a function of
melting temperature, Tm (Eq.5, Table 1). A correlation between cell
viability and protein stability is observed; overall, the viability is higher
for SOD1 mutants with low Tm. SOD1 variants with mutated Zn
2+
ligands as well as [F64A] and [D124G], all with a diminished ability to
bind Zn
2+, fall outside of this pattern (red symbols) (for detailed
information, c.f. Table 1). The line represents a sigmoidal fit (Eq. 5) of all
data points, except those from mutants with diminished ability to bind
Zn
2+.( B) Monomeric apoSOD1 (#) induces a toxic response, whereas
[H63/71/80S;D83S] (%), [H71/80S;D83S] (n), [H71/80S] (,) and [H71S]
(e) are all non-toxic. As all of these mutants lack H71, this amino acid
was engineered back into [H63/71/80S;D83S] and [H71/80S;D83S],
creating the mutants [H63/80S;D83S] (6) and [H80S;D83S] (V).
However, these mutants show no effect on cell viability, indicating
that it is the concerted action of the Zn
2+ ligands that underlies the
toxicity, not H71 alone. Proteins were added in duplicate and data are
presented as mean percentage of buffer control 6 range.
doi:10.1371/journal.pone.0036104.g003
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heteronuclear NOE NMR relaxation experiments [33,34]. The
results show that monomeric holoSOD1 undergoes overall small
and uniform dynamic motions in loops IV and VII (Figure 4). This
restricted flexibility is revealed by the uniformly low and even
values of R1/R2 and (NOE-1)R1, which are typical for well
ordered, globular proteins [35]. Upon removal of the metal ions,
however, loops IV and VII undergo marked, local changes seen as
a simultaneous increase in the R1/R2 and (NOE-1)R1 values, i.e.
the regions of loops IV and VII gain dynamic mobility and
become more flexible (Figure 4). Accordingly, the gain of cytotoxic
function upon demetallation seems to coincide with increased loop
dynamics. Since loops IV and VII are the only regions to show
structural differences upon demetallation, it is further implicated
that this part of the SOD1 structure is directly coupled to the gain
of cytotoxic function in the cultured-cell system.
Mutation of the Zn
2+-binding ligands abolishes the
cytotoxic effect of apoSOD1
From a functional perspective, the active-site loops structures in
SOD1 play a key role by binding the Cu
1+/2+ and Zn
2+ ions. The
Zn
2+ ion is coordinated by three histidines, H63, H71 and H80,
and one aspartic acid, D83, all located in loop IV. H63 also
coordinates Cu
1+/2+ together with H46, H48 and H120. To
investigate the role of Zn
2+ binding and the Zn
2+-binding side
chains in the cytotoxic action of SOD1, we produced the
mutations [H63/71/80S;D83S], [H71/80S;D83S], [H71/80S]
and [H71S]. Notably, all of these variants with mutated Zn
2+
ligands show up as clear outliers in the stability vs. cell viability plot
(Figure 3A, within square): they are virtually non-toxic even
though they show wild-type like stability and are well folded under
the experimental conditions. In contrast, the apo state of the Cu
1+/
2+-ligand mutant [H46/48/120S], which has retained affinity for
Zn
2+ [36], induces a toxic response of a magnitude that is expected
from its protein stability (Table 1). Conversely, the SOD1 variants
[F64A] and [D124G], both with a reduced affinity for Zn
2+
(Figure S3, [37]), fall outside of what can be expected from protein
stability alone (Table 1). As the Zn
2+-ligand mutants all lack the
residue H71, this amino acid was engineered back creating the
new variants [H63/80S;D83S] and [H80S;D83S]. However, this
modification had no discernable effect on the cell viability
(Figure 3B), demonstrating that the toxic effect is not mediated
by this single amino acid alone. Rather, the cytotoxicity seems to
require an intact high-affinity Zn
2+ site. As a further test of the
toxicity mechanism, we demonstrated that the apoSOD1 toxicity
could not be inhibited by heparin, generally expected to compete
with heparan sulphate binding sites (Data not shown). Thus, the
cytotoxicity observed in this study is unlikely related to interaction
of Zn
2+-binding residues with heparan sulphate as observed for the
Ab peptide implicated in Alzheimer’s disease [38,39].
The apoSOD1 toxicity builds up over time and can be
halted by Zn
2+ addition
To examine the time dependence of the cytotoxic response, two
approaches were attempted to neutralize the cytotoxic apoSOD1
protein; (i) washing off the protein from the cells by exchanges of
the culture media and (ii) addition of Zn
2+ ions to the culture
media. The results showed that washing off the monomeric
apoSOD1 protein after less than 30 h of incubation completely
saved the cells. In a parallel control experiment, where the
addition of apoSOD1 was delayed after the start of the incubation,
it was further demonstrated that 30 h incubation with the protein
is the time needed for cell death to commence (Figure 5A). These
observations indicate that the reduced viability caused by
apoSOD1 is integrated - builds up - over time, as opposed to an
early decisive event that predisposes the cells for death.
Consistently, when Zn
2+ was supplied to the culture media within
30 h after the addition of apoSOD1 [H46/48/120S] the cells
were also saved, following the same time dependence as observed
when apoSOD1 was washed off from the cells (Figure 5B). No
other metals tested, including Cu
2+ and Fe
2+/3+, saved the cells
from cytotoxicity (Figure S4). Zn
2+ reduced the toxicity almost
completely (80% viability) at equimolar concentration, indicating
that Zn
2+ binding to free apoSOD1 in the culture medium stops
Zn
2+ depletion of the cells (Figure S4A). In a second experiment,
apoSOD1 was added at a concentration where viable cells are still
remaining at the endpoint of the experiment (32% viability). None
Figure 4. Loss of Cu
1+/2+ and Zn
2+ ions leads to increased
backbone dynamics of the active-site loops IV and VII. The
backbone dynamics of monomeric apo- and holoSOD1 evaluated by
NMR relaxation experiments. (A) Structural representation of the SOD1
monomer showing the regions of increased dynamic motions in the
apo state. (B) Amino-acid sequence of loops IV and VII. (C) Increased
dynamics in the intermediate time scale is indicated by increased values
of R1/R2 and increased fast dynamics as increased negative values of
(NOE-1)R1. In the apoSOD1 monomer, the regions of loops IV and VII
show increased dynamics [31], whereas in the metallated monomer [71]
the loops are as fixed as the rest of the protein. Figure outline adapted
from Nordlund et al. [32].
doi:10.1371/journal.pone.0036104.g004
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(Figure S4B), suggesting that these metals do not interact with
apoSOD1 in such a way that free radicals or other noxious
processes emerge. These data, again, point at the ability of
apoSOD1 to coordinate Zn
2+ as the key determinant for the toxic
effect.
Reduced cell viability exerted by apoSOD1 is not
dependent on serum
To examine if apoSOD1 induces toxicity through alteration of
serum components, the effect of monomeric apoSOD1 on cell
viability was evaluated also under totally serum-free conditions.
The results show that the toxicity is not dependent on serum: the
toxic effect of apo SOD1 remains under serum-free conditions
(Figure S5).
Addition of Zn
2+ chelators induces a toxic response
similar to that of apoSOD1
One explanation for the requirement of un-metallated, high-
affinity Zn
2+ sites for the apoSOD1 cytotoxicity is Zn
2+ chelation.
The level of free Zn
2+ ions in the cytoplasm is regulated through a
system of proteins buffering Zn
2+ and transporting Zn
2+ in and out
of the cell [40]. Disturbances in this balance can be deleterious
[41]. Of particular interest for this study is that the addition of
Zn
2+ chelators is previously reported to have pronounced effects
on the viability of cultured cells [42,43,44]. Even if TPEN and
DTPA show high affinity for other divalent cations, their cell
toxicity have in several studies been attributed to the specific
chelation of Zn
2+; in essence, their cytotoxic effect is preferentially
inhibited by addition of Zn
2+ ions [43,45,46,47]. To compare the
toxic response of apoSOD1 with that of high-affinity Zn
2+
chelators, we incubated monomeric apoSOD1 in parallel with
equimolar amounts of N,N,N9,N9-Tetrakis(2-pyridylmethyl)ethy-
lenediamine (TPEN, membrane permeable) and Diethylene
triamine pentaacetic acid (DTPA, membrane impermeable). The
results show that apoSOD1 was slightly less toxic than TPEN, but
considerably more toxic than DTPA (Figure 6A). However, the
reason for this difference is not necessarily related to the limited
membrane permeability of DTPA, but can also arise from
competing uptake of other divalent ions, e.g. Ca
2+, present at
high concentrations (mM) in the culture media. Thus, the
relatively low toxicity of DTPA could simply be due to partial
saturation by Ca
2+ [44,48,49], which reduces the chelator’s
capacity to scavenge free Zn
2+. Moreover, we observe that
phase-contrast images of cells exposed to TPEN agree with the cell
viability data by displaying cells with a rounded-up appearance,
closely resembling cells incubated with apoSOD1 (Figure 6B).
Together with the similar effect of apoSOD1 and TPEN on the
cell viability as measured by the MTT assay, this observation
supports the idea that the toxicity mechanism of apoSOD1 in this
model involves Zn
2+ chelation.
Zn
2+ is transferred from the cells to the apoSOD1 protein
To examine if intracellular Zn
2+ is actually transferred from the
cells to the SOD1 protein during the cytotoxic action, cells were
loaded with the radioactive isotope
65Zn by incubating the cells in
cell media containing
65Zn. After washing and replating the cells
under serum-free conditions, 10 mM of monomeric apoSOD1
[C6/111A;F50E;G51E] and the mutants [H46/48/120S], [H71/
80S;D83S] and [H46/48/63/71/80/120S;D83S] were added to
the culture media. The monomeric apoSOD1 [C6/
111A;F50E;G51E] protein was determined by ICP-MS to initially
contain 0.03 mol Zn
2+/mol SOD1 (analyzed by ALS Scandinavia,
Sweden).
After 70 h of incubation, culture media samples were collected,
concentrated dry on cellulose filters and analyzed for
65Zn content
by exposing the filters to a phosphoimaging screen together with a
standard series of known
65Zn concentrations applied to
nitrocellulose. Sample handling times were kept as short as
possible, i.e. less than 1.5 h, to minimise
65Zn loss from the protein
by dynamic breathing [36]. After 70 h of incubation, cell viability
was significantly reduced for cells incubated with the toxic
apoSOD1 [C6/111A;F50E;G51E] and [H46/48/120S], whereas
cells incubated with the non-toxic [H71/80S;D83S] and [H46/
48/63/71/80/120S;D83S] were fully viable (Figure 7A). The
toxic apoSOD1 [C6/111A;F50E;G51E] and [H46/48/120S]
contained 87% and 73%
65Zn, respectively (Figure 7C), where
100% is the level if all
65Zn available in the cells (quantified to
1.9 fmol/100 000 cells) would transfer to the protein. As expected,
the ratio of
65Zn bound to the non-toxic proteins [H71/
80S;D83S] and [H46/48/63/71/80/120S;D83S] were signifi-
cantly lower at 27% and 5%, respectively. The results show that
the cytotoxicity in this study is accompanied by transfer of
intracellular Zn
2+ ions to extracellular apoSOD1, consistent with
Figure 5. ApoSOD1 toxicity builds up over time and can be
halted by Zn
2+ addition. 10 mM monomeric apoSOD1 was first
added to multiple wells of SH-SY5Y cells and then washed away after
different times of incubation. In parallel to washing, 10 mM monomeric
apoSOD1 was also added to untreated cells. In a second line of
experiments, 10 mM monomeric apoSOD1 [H46/48/120S] was added to
the cells and, after different times of incubation, 20 mM of ZnCl2 was
added. MTT was added at the endpoint (72 h) of both experiments.
Proteins were added in duplicate and data is presented as mean
percentage of the buffer control 6 range. (A) Washing away the
apoSOD1 protein after different length of incubation (#) induces the
same toxicity as when adding the protein the same number of hours
before the endpoint of the experiment (&). (B) Adding Zn
2+ to the cell
media after different delay times has the same effect on cell viability as
washing the protein away. Filled and empty symbols represent separate
experiments.
doi:10.1371/journal.pone.0036104.g005
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quantification of
65Zn, the relatively lower
65Zn contents of the
non-toxic mutants with decreased Zn
2+ affinity support the
conclusion that the cytotoxic action of apoSOD1 is linked to the
uptake of Zn
2+ ions.
Discussion
Cytotoxicity induced by extracellularly added SOD1 is
independent of aggregation
Even though SOD1-positive inclusions are observed both in
familial [50] and sporadic ALS [51,52], as well as in transgenic
mice [53], SOD1 lacking C6 and C111 stands out as a relatively
soluble protein in vitro. Aggregation needs to be triggered by
agitation under reducing or otherwise destabilizing conditions
[5,28]. Consistently, no SOD1 aggregates could be detected at the
endpoint of our cell experiments (Figure 2C). Instead, the reduced
cell viability arose from the chromatographic fractions containing
soluble apoSOD1 monomers (Figure 2B) and dimers (Figure 2A).
It is thus apparent that the cytotoxicity of apoSOD1 in this study
does not rely on protein aggregation. This observation contrasts
studies of other precursors of neurodegenerative diseases, e.g. Ab
[29], a-synuclein [54] and transthyretin [55], where aggregation is
implicated as the prime cause of toxicity in cell cultures. Moreover,
the coupling between decreased cell viability and high apoSOD1
stability (Figure 3A) indicates the folded protein as the cytotoxic
species. A similar correlation has been reported for the protein
Onconase A [56], which is an RNaseA homolog with specific
cytotoxic activity against cancer cells. In the case of Onconase A,
however, the cytotoxicity depends on the protein’s ability to evade
proteolysis [56]. A yet different toxicity mechanism has been
Figure 6. Zn
2+ chelators induce a toxic response similar to that
of apoSOD1. The high-affinity Zn
2+ chelators TPEN and DTPA were
dissolved in DMSO and added to SH-SY5Y cells in parallel with
monomeric apoSOD1 in a concentration range of 0.16 to 20 mM, and
incubated for 72 h before addition of MTT. The final concentration of
DMSO in the cell culture was 0.1%. (A) TPEN (n) induces a toxic
response similar to that of monomeric apoSOD1 (#), whereas DTPA
(%) shows an overall weaker effect. Chelators and apoSOD1 protein
were added in duplicate and data are presented as mean percentage of
vehicle control 6 range. (B) Phase contrast images of cells exposed to
10 mM monomeric apoSOD1, 10 mM TPEN and 10 mM DTPA. Cells
incubated with apoSOD1 closely resemble cells incubated with TPEN.
doi:10.1371/journal.pone.0036104.g006
Figure 7. Intracellular Zn
2+ is transferred to cytotoxic apoSOD1
proteins. Monomeric apoSOD1 [C6/111A;F50E;G51E] (1) and the
mutants [H46/48/120S] (2), [H71/80S;D83S] (3) and [H46/48/63/71/80/
120S;D83S] (4) were added to a final concentration of 10 mM to SH-SY5Y
cells loaded with radioactive
65Zn. Samples of the culture media were
collected, concentrated dry on a 10 K filter and exposed to a phospho-
imaging screen. As reference for signal quantification, we used lysate of
65Zn-loaded cells and a standard series of known
65Zn concentrations.
Cell viability was measured in a parallel experiment. (A) Monomeric
apoSOD1 [C6/111A;F50E;G51E] and [H46/48/120S], which both show
high Zn
2+ affinity, reduce cell viability to below 20%, whereas the low
Zn
2+ affinity mutants [H71/80S;D83S] and [H46/48/63/71/80/120S;D83S]
have no significant effect on cell viability. (B) Filter radioactivity showing
transfer of
65Zn to the different SOD1 variants in panel A. The signal
intensity declines with decreasing Zn
2+ affinity of the apoSOD1 proteins
concentrated on the filter. The high-density patterns in 1 and 2 result
frommanufactureddepressions inthefiltersurface.(C) Themolar ratioof
Zn
2+ to SOD1 decreases with the Zn
2+ affinity of the protein. 100% is the
ratio expected if all
65Zn present in the cells (quantified to 1.9 fmol/
100 000 cells) would transfer to the protein. (D) Plot of cytotoxic
response (1-viability %) vs. molar ratio of Zn
2+ to SOD1.
doi:10.1371/journal.pone.0036104.g007
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with negative glycolipids in the plasma membrane. Characteristic
to this type of mechanism is that it depends critically on the
proteins net charge: an increase of the global charge of RNaseA
from 27t o+3 was found to decrease the toxicity drastically [57].
In the case of SOD1, however, we observe no corresponding effect
of changing the global charge from 28t o22 (Table 1), suggesting
that the cytotoxic mechanism is of different origin. Judging by the
NMR analysis (Figure 4) and the ability of Zn
2+ to inhibit
cytotoxicity (Figure 5B), the action of apoSOD1 seems rather
linked to the structural properties of the active-site loops IV and
VII.
ApoSOD1 toxicity requires empty, high-affinity Zn
2+ sites
From the data in Figure 3 it is clear that several apoSOD1
mutants deviate from the viability vs. stability plot. Common to
these outliers is that they lack toxicity even though they remain
folded in the culture media. Common to the outliers is also that
they affect the Zn
2+-binding capacity of the apoSOD1 molecule.
Substitution of only one Zn
2+-binding ligand (i.e. H71) is enough
to render the protein non-toxic (Figure 3B). This, in combination
with the lack of toxicity of holoSOD1 (Figure 1A, 1B) and the
inhibitory effect of Zn
2+ supplementation (Figure 5B), but not
other metals (Figure S4), on the apoSOD1 toxicity, points at the
actual uptake of Zn
2+ as the prime cause of cytotoxic function.
Without exception, the mutants that cannot coordinate Zn
2+ with
sub mM affinity have no effect on cell viability and cluster in the
top-right corner of the viability vs. protein stability plot (Figure 3A).
Consistently, alterations of the neighbouring Cu
1+/2+ ligands,
which have only small influence on the Zn
2+ affinity, have no
corresponding effect on cell viability: the mutant [H46/48/120S],
which completely truncate the native Cu
1+/2+ site, exerts perfectly
wild-type like toxicity (Table 1). Taken together, this toxicity
pattern does not comply with the earlier observations by Estevez et
al. where the toxicity of Zn
2+-deficient SOD1 is dependent on the
redox-active Cu
1+/2+ ion, allowing the production of noxious
peroxynitrite radicals [20]. Also, the inability of Cu
1+/2+ and Fe
2+/
3+ to increase cytotoxicity (Figure S4B) argues against the
involvement of a redox-active metal interacting with the Zn
2+
site. The toxicity observed in this study seems instead to rely on the
apoSOD1 molecule’s ability to bind Zn
2+.
Toxicity by Zn
2+ chelation
As the apoSOD1 cytotoxicity seems to rely on Zn
2+ affinity,
Zn
2+ chelation stands out as the most reductionist and plausible
underlying mechanism. Given a Zn
2+ level of 0.4 fmol/cell [58],
the Zn
2+ content in the culture wells provided by the cells (30000
cells in a culture volume of 100 ml) corresponds to 120 nM. The
background level of Zn
2+ in the culture media with 0.5% serum, as
used in these experiments, is estimated to 200 nM based on known
Zn
2+ levels in supplemented media with 10% serum [59]. This
Zn
2+ content is well within the binding range of the mM apoSOD1
levels observed to induce toxicity in this study; the Zn
2+ affinity for
SOD1 is ,nM [60,61]. In direct support of this idea, low
molecular weight Zn
2+ chelators have in several studies been
shown to be toxic to cultured cells [42,43,62]. In the simplest case,
chelation of Zn
2+ is deleterious because several essential proteins
depend critically on Zn
2+ for their function. One example is
coordination of Zn
2+ to the active site of histone deacetylases, a
class of enzymes that control DNA integrity and gene expression
[63]. Inhibitory binding of small organic molecules to the Zn
2+ site
of this protein has even emerged as a promising strategy in cancer
therapy [64,65].
In striking resemblance with the observations in the present
study, extracellular Zn
2+ depletion is implicated in the toxic action
of calprotectin, a Ca
2+- and Zn
2+-binding protein that reduces cell
viability in a Zn
2+-reversible manner [66]. A distinct feature of the
calprotectin toxicity is that it does not require direct cell contact:
depleting Zn
2+ from the surrounding growth medium appeared to
be enough. Thus, it is reasonable to assume that the apoSOD1
toxicity can also be exerted without direct cell contact (Figure 8).
Concluding remarks
The reductionist conclusion from this study would be that the
observed cytotoxicity based on Zn
2+ chelation constitutes an
artefact of an overly simplistic cell model, rather than a true
component of the ALS mechanism. Nevertheless, since cultured
cells represent one of the most commonly employed toxicity
models in neurodegenerative disease, such an inherent sensitivity
to the Zn
2+ levels could have critical implications for the
interpretation of data. Not only in studies of metalloproteins, but
also in studies of protein aggregates in general, which are known to
coordinate ions in a more unspecific manner [67]. The
corresponding effects of chelating Zn
2+ in intact neural tissue,
and whether such perturbations play any role in protein-
aggregation disease, are yet to be found out. There is, however,
increasing evidence for the importance of Zn
2+ in synaptic
transmission and plasticity, as well as the importance of
maintained Zn
2+ homeostasis in cell survival [58,68]. It is therefore
conceivable that apoSOD1, if secreted or transferred to the
extracellular space by cell lysis, could modulate the propagation of
neuronal damage in ALS [6]. Dietary Zn
2+ supplementation has
also been shown to be protective in G93A mice [69]. Still, based
on the data at hand, the apoSOD1 toxicity mediated by Zn
2+
chelation is most likely limited to the cell model of this study and
not the trigger of human ALS. From a methodological standpoint,
our results show also that rational protein engineering in
combination with biophysical analysis can be used to produce
protein specific data that correlate quantitatively with the cellular
Figure 8. Schematic outline of how apoSOD1 exerts toxicity to
cultured cells. Protein stability (DGU/F) determines the relative
concentrations of unfolded ([U]) and folded ([F]) apo protein and, thus,
the effective concentration of species able to chelate Zn
2+ from the
growth medium. For stable mutations where [F]apo&[U], the protein
acts as an efficient Zn
2+ chelator, disturbing the cellular Zn
2+
homeostasis. In the most simplistic case, the apoSOD1 molecules do
not interact with the cells but lower the intracellular Zn
2+ levels by
preventing reflux from the growth medium.
doi:10.1371/journal.pone.0036104.g008
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Methods
Protein expression and purification
To ensure good metal loading, SOD1 was co-expressed with the
yeast Cu-chaperone CCS in E.Coli. The bacterial cultures were
grown at 23uC, and CuSO4 (3 mM) and ZnSO4 (30 mM) were
added upon induction. Purification was done by heat denaturation
(55uC for 30 min) followed by ammonium sulfate precipitation, gel
filtration (S100 Sephacryl 100, Amersham Pharmacia), and ion-
exchange chromatography (Q-Sepharose) [11]. The metal content
for the monomeric holo protein was determined to 80% zinc and
20% copper (data not shown), using Total Reflection X-ray
Fluorescence (TXRF).
Apo procedure
Apo protein was prepared by adding the protein solution to a
Slide-a-Lyzer mini dialysis tube (Pierce) placed in a solution of
4 M of guanidinium chloride, 10 mM of MES buffer and 250 mM
of EDTA for a minimum of 4 h at room temperature. The protein
was subsequently dialyzed against 10 mM MES buffer. The apo
state of the protein was verified by standard folding assays
(chevron plots) [4,11] and melting curves as described in the
Methods section. Any traces of holoSOD1 or misfolded protein
would appear as extra phases/transitions, added to those of the
apo species. In addition, a sample of monomeric apoSOD1 was
analyzed with ICP-MS (ALS Scandinavia, Sweden), and deter-
mined to contain a molar fraction of 0.03 Zn
2+.
Cell cultures
Human neuroblastoma SH-SY5Y cells were cultured in
Dulbecco’s Modified Eagle Medium (D-MEM, Gibco) supple-
mented with 10% FBS, 100 units/ml penicillin, 100 mg/ml
streptomycin, 250 mg/ml amphotericin B and 5 mg/ml plasmocin,
at 37uC in a humidified atmosphere of 5% (v/v) CO2/air.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay
SH-SY5Y cells were detached with trypsin and seeded in D-
MEM without phenol red supplemented with 1% FBS at a density
of 57 000 cells/cm
2 in 96-well plates and grown over night. Prior
to treatment, serumfree D-MEM was added resulting in a final
serum concentration of 0.5%. SOD1 protein was incubated with
the cells for 72 h, and cell viability was assessed at the end of the
experiment by addition of MTT in a final concentration of 5 mg/
ml and further incubation for 4 h. The formazan product was
dissolved with 20% SDS in 50% dimethyl formamide, and
absorbance measured at 570 nm (Spectramax 340 PC). This
endpoint measurement determines the total amount of viable cells
at the end of the experiment, both adherent cells and possible
floaters.
Resazurin assay
SH-SY5Y cells were detached with trypsin and seeded in
supplemented MEM (c.f. Text S1) without phenol red at a density
of 40 000 cells/cm
2 in 96-well plates and incubated for 24 h. Prior
to addition of SOD1, the media was exchanged for MEM without
serum. SOD1 protein was incubated with the cells for 72 h, and
cell viability was assessed by addition of resazurin in a final
concentration of 0.01 mg/ml to each well and further incubation
for 3 h. Fluorescence was measured using a Tecan Infinity
fluorescence microplate reader with excitation at 535 nm and
emission at 595 nm.
Cell imaging
SH-SY5Y cells were plated at a density of 40 000/cm
2 in lab tek
II slides (Nunc) and fixed in 4% (w/v) paraformaldehyde.
Unspecific binding sites were blocked in 10% goat serum, and
microtubuli were visualized using an anti-b-tubulin antibody (Cell
Signalling) and a rhodamine labelled secondary antibody (Rock-
land). The slide was mounted with Vectashield mounting medium
containing 1 mg/ml DAPI (Vector Labs) to visualize nuclei and
examined in an inverted Zeiss Axiovert 40 CFL microscope
equipped with epifluorescence and a digital Aciocam ICc1
camera.
Test of SOD1 aggregation by size-exclusion
chromatography
Monomeric and dimeric apoSOD1 protein was separated on a
Superdex 75 10/300 column (GE Biosciences) equilibrated with
MEM without phenol red. The eluted fractions were supplement-
ed with Non-Essential Amino Acids solution (NEAA), 2 mM L-
glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin, and
1 mg/ml bovine serum albumin prior to incubation with SH-
SY5Y cells. For test of the aggregation state of dimeric apo SOD1
at the endpoint of the viability assay, the samples were centrifuged
at 1000 G for 10 min to remove non-adherent cells prior to the
chromatography.
Immunoblotting
For western immunoblots an antibody raised against a peptide
corresponding to residues 24–39 in the human SOD1 sequence
was used as previously described in Jonsson et al. [70]. For
quantification, chemiluminescence were recorded with a Chemi-
DOC XRS (Bio-Rad, Hercules, CA, USA) and analyzed with
Quantity One software (Bio-Rad). SOD1 in each fraction is given
as percentage of total eluted SOD1.
CD spectroscopy
The melting temperature (Tm) of each apoSOD1 mutant was
determined by CD spectroscopy using a Jasco J-815 equipped with
a peltier temperature controller. Proteins were dialyzed against
phosphate buffer pH 7.5 (alternatively diluted in the same buffer)
before analysis. Thermal denaturation was achieved by increasing
the temperature (T) from 5 to 95uC with a rate of about 1uC/min.
At each temperature increment, the CD signal (h) was integrated
between 222 and 236 nm. Assuming a first-order unfolding
transition between folded (F) and unfolded (U) protein, the
resulting plot of h vs. T was fitted by the sigmoidal function
h~
aFzbFT ðÞ z aUzbUT ðÞ e
- DGU=F T ðÞ

=RT
1ze
- DGU=F T ðÞ

=RT
ð3Þ
where DGU/F(T) is the protein stability (Eq. 4), and (aF+bFT) and
(aU+bUT) are the base lines for the folded and unfolded states,
respectively.
DGU=F T ðÞ ~DHU=F Tm ðÞ 1{T=Tm ðÞ {
DCp Tm{T ðÞ zln T=Tm ðÞ ðÞ ð4Þ
where DHU/F(Tm) is the absorbed heat upon unfolding (i.e.
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heat capacity difference between U and F.
NMR spectroscopy
Standard T1,T 2 and steady-state heteronuclear NOE experi-
ments were performed on a Bruker 600 MHz spectrometer
(Bruker Avance, Karlsruhe, Germany) equipped with a room
temperature triple-resonance probe. All experiments were done at
25uC and pH 6.3 with 220–350 mM SOD1. In holo SOD1, Cu
2+
was substituted with Zn
2+. Spectra were transformed using
nmrPipe and analyzed by Sparky (T. D. Goddard and D. G.
Kneller, SPARKY 3, UCSF). In the T1 and T2 experiments the
signal attenuation from 10 different relaxation delays was fitted to
a single-exponential decay.
Normalization and fitting of cell viability data
To have a measure of the total viability response of each mutant
in Figure 3A, the area under each viability curve was calculated
using Graphpad prism 5.0 and normalized against buffer and
monomeric apoSOD1 within each individual experiment using
the following expression: (areamutant-areaapoSOD1)/(areabuffer-
areaapoSOD1). In this way, buffer was set to 100% viability and
monomeric apoSOD1 to 0% viability. The dataset was subse-
quently fitted to a sigmoidal function, describing how the total cell
viability response (Y) depends on the melting temperature (Tm)o f
the individual protein mutants,
Y~
amaxzamine
mT m{T50 ðÞ
1ze
mT m{T50 ðÞ
ð5Þ
where amin is the bottom base line, amax the upper base line and
T50 is the Tm value at which the viability has been reduced to
50%, i.e. the transition midpoint. The value m defines the width of
the sigmoidal transition between amax and amin. Data was fitted
with graphpad prism v.5.0.
Loading of cells with
65Zn
SH-SY5Y cells were incubated with 200 kBq of
65ZnCl2
(theoretical specific activity: 305 GBq/mg
65Zn) (Perkin-Elmer,
45 MBq/mg total Zn
2+) in 10 ml of supplemented cell medium for
72 h. Radioactive medium was removed, and the cells were
washed 26 with PBS and 16 with 5 mM EDTA in PBS. Cells
were detached and plated in serum free medium (100 000/well for
96 well plate, 570 000/well for 24 well plate). 10 mM of apoSOD1
was added and incubated with the cells for 70 h, after which
samples of culture media was collected from the 24 well plate, and
cell viability measured on the 96 well plate using the MTT assay.
Cellular uptake of
65Zn
1610
6 cells loaded with
65Zn were pelleted at 15006 g for
5 min and the supernatant removed. The cell pellet was lysed in
100 ml cold cell lysis buffer (50 mM Tris-HCl 150 mM NaCl
pH 7.5, 1% NP-40, protease inhibitor cocktail) and incubated for
5 min at 4uC. Cell debris was pelleted at 13 0006g for 10 min at
4uC, and the supernatant was collected and applied to a
nitrocellulose membrane.
Filter assay and quantification of
65Zn transfer to
apoSOD1
The collected samples of culture media were centrifuged at
15006g for 5 min, and 500 ml of the supernatant was concentrated
dry on a 10 K cellulose filter at 14 0006 g for 1 h using mini
concentration tubes (Millipore). The amounts of radioactive
65Zn in
the filters were determined by phospho-imaging. As references for
quantification, we used cell lysate and a standard series of known
concentrations of
65Zn applied to nitrocellulose. The phospho-
imaging detection matrix was scanned (Fuji FLA-3000) and pixel
intensities were quantified using the MultiGauge software (Fujifilm).
The calculations of
65Zn/SOD1 stoichiometry were based on
10 mM SOD1 (measured by absorbance at 280 nm), i.e. the
concentration of SOD1 in the culture media during the toxicity
experiment. According to the chromatographic analysis in
Figure 2C the concentration of SOD1 in the culture medium
remains approximately constant during the toxicity experiment.
Supporting Information
Figure S1 Dimeric apoSOD1 is cytotoxic to three
different cell lines. Dimeric apoSOD1 was added to three
different cell lines in a final concentration of 5 mM and incubated
for 72 h. Cell viability was measured using the resazurin assay.
Proteins were added in triplicate and data are presented as mean
6 SD as percentage of the buffer control. ApoSOD1 (white bars)
reduced cell viability in all three cell lines, whereas holoSOD1
(grey bars) was non-toxic.
(TIFF)
Figure S2 Fluorescence microscopy of cells exposed to
apo and holoSOD1. Cells were visualized with immunocyto-
chemistry, using DAPI for DNA staining (blue) and an anti-tubulin
antibody for staining of the cytoskeleton (red). (A)M o n o m e r i c
holoSOD1 (5 mM) does not cause any visible cell death after 72 h of
incubation(2006magnification).(C)Fewcellsremainafterexposure
to 5 mM monomeric apoSOD1 for 72 h (2006magnification).
(TIF)
Figure S3 The thermal transition of apoSOD1 F64A is
not affected by Zn
2+. Zn
2+ was added in 5 to 7 molar excess to a
protein solution of monomeric apoSOD1 F64A (A) or monomeric
apoSOD1 (B) heated to 37uC (310 K). The solutions were further
incubated for 4–5 h, where after a melting curve was obtained and
compared to the thermal transition of each protein incubated
without Zn
2+. For F64A, the two experimental conditions resulted
inindistinguishable melting curves, demonstrating very poor affinity
of the protein for Zn
2+. As expected, monomeric apoSOD1
incubated with Zn
2+ results in a protein with significantly higher
melting point, demonstrating high affinity for Zn
2+.
(TIF)
Figure S4 Addition of Zn
2+ saves the cells from
apoSOD1 induced cytotoxicity. Cells were incubated with
either 10 mM monomeric apoSOD1 [H46/48/120S] (A)o r1mM
monomeric apoSOD1 [H46/48/120S] (B) together with various
metals. Protein and metals were added at the start of the
experiment, and cells were subsequently incubated for 72 h. Cell
viability was measured using the MTT assay. Proteins were added
in triplicate and data are presented as mean and range as
percentage of buffer control. The metal concentration in the
culture medium was varied between 40 mM (red), 20 mM (purple),
10 mM (green), 5 mM (orange) and 2.5 mM (blue). Addition of
Zn
2+ in equimolar concentration saves the cells almost completely,
indicating that Zn
2+ detoxifies apoSOD1 by filling the empty Zn
2+
site. None of the other metals tested, i.e. Fe
2+,F e
3+.N i
2+,M n
2+ or
Cu
2+, have this effect. Addition of an excess concentration of metal
to a lower concentration of apoSOD1 do not increase toxicity
indicating that these metals do not interact with the protein in such
a way that harmful free radicals can be formed or other toxic
pathways commence.
(TIF)
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under serum free conditions. Cells were incubated with
monomeric apoSOD1 in cell media without serum or under
standard conditions, i.e. media supplemented with 0.5% serum.
Cell viability was measured using the MTT assay. Proteins were
added in duplicate and data are presented as mean and range as
percentage of the buffer control. The effect of apoSOD1 on cells
with or without serum is of a similar magnitude.
(TIFF)
Text S1 Cell growth and treatment conditions for
supporting figures and Figure 2.
(DOC)
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